1.Helicobacter pylori and Telomerase Activity in Intestinal Metaplasia of the Stomach.
Il Kwun CHUNG ; Kyu Yoon HWANG ; In Ho KIM ; Hong Soo KIM ; Sang Heum PARK ; Moon Ho LEE ; Chang Jin KIM ; Sun Joo KIM
The Korean Journal of Internal Medicine 2002;17(4):227-233
BACKGROUND: Helicobacter pylori (H. pylori) has been considered a definitive carcinogen in gastric cancer. Telomerase is activated in gastric cancer and some premalignant gastric lesions, including intestinal metaplasia (IM). In this study, we evaluated the relationships of both H. pylori infection and telomerase activity with endoscopic and histologic features in IM. The effects of H. pylori eradication on endoscopic, histologic and biochemical changes were evaluated. METHODS: Endoscopic biopsies were obtained from 43 patients with IM for rapid urease, histologic and telomerase tests. The endoscopic and histologic features, H. pylori infection and telomerase were assessed. After H. pylori eradication, 15 patients were re-evaluated and compared after 4 months. RESULTS: Thirty-four (79.1%) patients were infected with H. pylori. The incidence of H. pylori infection was borderline correlated to the severity of IM (p=0.076). Telomerase was elevated in eight (18.6%) patients. Telomerase tends to be high in subtype III and endoscopic grade III of IM. After H. pylori eradication, endoscopic extent (p=0.039) and histologic severity (p=0.074) showed improvements, and telomerase decreased significantly (p=0.0001). CONCLUSION: Our data suggest that telomerase is associated with the severity and extent of IM and that H. pylori eradication improves the endoscopic and histologic features in IM, and decreases telomerase activity. H. pylori eradication can be considered one of the methods to prevent gastric cancer in patients with H. pylori-infected IM. Further long-term and large-scaled study will be needed.
Female
;
Helicobacter Infections/*enzymology
;
*Helicobacter pylori
;
Human
;
Intestinal Mucosa/enzymology/microbiology/*pathology
;
Male
;
Metaplasia/enzymology/microbiology
;
Middle Aged
;
Precancerous Conditions/enzymology/microbiology
;
Stomach Neoplasms/*enzymology/microbiology
;
Telomerase/*metabolism
2.COX-2 expression in the H. pylori infected gastric mucosal epithelia and its significance.
Xiao-yun DING ; Ding-guo LI ; Han-ming LU
Chinese Journal of Oncology 2005;27(4):232-234
OBJECTIVETo study COX-2 expression in H. pylori infected gastric mucosal epithelia and its significance in the carcinogenesis of the stomach.
METHODSRapid urease test and histological examination with basic magnenta staining were used to assess the status of H. pylori infection in the stomach. COX-2 was detected immunohistochemically.
RESULTSCOX-2 immunostaining was positive in 1 out of 12 cases with H. pylori-negative gastric mucosa and also in 1 out of 10 cases with H. pylori-positive gastric mucosa without macroscopic alterations, while COX-2 expression was found to be positive in 5 out of 9 cases with H. pylori related superficial gastritis with mucosal erosions. COX-2 expression was detected in 5 out of 10 cases with H. pylori-positive mild atrophic gastritis, 8 out of 10 cases with H. pylori-positive moderate-severe atrophic gastritis and intestinal metaplasia, and 6 out of 8 cases with H. pylori-positive moderate-severe dysplasia. COX-2 expression was positive in 22 out of 32 cases of gastric cancer.
CONCLUSIONH. pylori may induce COX-2 expression of gastric mucosal epithelia in chronic superficial gastritis, which is related to the development of mucosal injury. According to gastric mucosal carcinogenesis pattern up-regulation of COX-2 expression is associated with gastric mucosal carcinogenesis, and involved in the early development of premalignant lesions.
Adult ; Aged ; Cyclooxygenase 2 ; biosynthesis ; genetics ; Female ; Gastric Mucosa ; enzymology ; Gastritis ; enzymology ; microbiology ; Helicobacter Infections ; enzymology ; Helicobacter pylori ; Humans ; Male ; Middle Aged
3.The Changes of Matrix Metalloproteinase-9 Expression in the Gastric Antral Mucosa after Helicobacter pylori Eradication: Immunohistochemical Study.
Heok Soo AHN ; In Hee KIM ; Seung Ok LEE ; Myoung Jae KANG ; Dae Ghon KIM ; Soo Teik LEE
The Korean Journal of Gastroenterology 2004;43(2):90-95
BACKGROUND/AIMS: In this study, we analysed the changes of matrix metalloproteinase-9 (MMP-9) expression in the gastric antral epithelium in respect to H. pylori eradication. METHODS: Twenty patients with H. pylori-positive chronic gastritis or peptic ulcer were studied. The expression of MMP-9 in the gastric antral biopsy specimens were compared before and after H. pylori eradication using immunohistochemical study. The positive rates and intensity of MMP-9 staining were evaluated at surface mucous cells and pyloric gland cells. RESULTS: The positive rate of MMP-9 staining in antral mucosal epithelial cells of H. pylori chronic gastritis is 63.8%. The positive rates of MMP-9 staining in the surface mucous cells and pyloric gland cells were 75.5% and 52.0% before H. pylori eradication, respectively. On the contrary, the rates were 85.5% and 82.0% after eradication. The MMP-9 overexpression in the pyloric gland cells were noticeably increased after H. pylori eradication. Strong positive staining of MMP-9 was increased significantly after H. pylori eradication in the pyloric gland cells. CONCLUSIONS: These results suggest that MMP-9 over-expression is associated with H. pylori infection as a host inflammatory response. The increased expression after H. pylori eradication indicates that MMP-9 may have a important role in remodeling or early tissue repairing process of gastric mucosa.
Adult
;
Aged
;
English Abstract
;
Female
;
Gastric Mucosa/*enzymology
;
Gastritis/drug therapy/enzymology/microbiology
;
Gelatinase B/*metabolism
;
Helicobacter Infections/drug therapy/*enzymology/microbiology
;
*Helicobacter pylori
;
Humans
;
Immunohistochemistry
;
Male
;
Middle Aged
;
Peptic Ulcer/drug therapy/enzymology/microbiology
;
Pyloric Antrum
4.The Change of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in the Gastric Mucosa One Year after Eradication of Helicobacter pylori.
Sung Soo KIM ; Young Jick SUNG ; Min Kyoung PARK ; Chang Hoon LIM ; Hong Jun YANG ; Tae Ho KIM ; Chang Whan KIM ; Jin Il KIM ; Sok Won HAN ; In Sik CHUNG
The Korean Journal of Gastroenterology 2008;52(5):286-292
BACKGROUND/AIMS: The cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), the proteins that have the role in the gastric carcinogenesis, are stimulated by H. pylori infection in the gastric mucosa. The aim of this study was to evaluate the expression of COX-2 and iNOS proteins one year after the eradication of H. pylori. METHODS: Gastric antral mucosa from fifty eight patients with chronic gastritis who were all infected with H. pylori was examined for the expression of COX-2 and iNOS proteins before and one year after the eradication of H. pylori by immunohistochemical stain. RESULTS: COX-2 and iNOS proteins were expressed in the epithelial cells and interstitial inflammatory cells of gastric mucosa. Percent expressions of COX-2 and iNOS were significantly decreased one year after the eradication in the patients with cured infection, but not in those having persistent H. pylori. COX-2 and iNOS expressions were well correlated with H. pylori density, acute and chronic inflammation of gastric mucosa. CONCLUSIONS: The eradication of H. pylori can decrease the expression of COX-2 and iNOS in the gastric mucosa in long-term period. This seems to be due to the removal of H. pylori itself and related regression of gastric inflammation.
Cyclooxygenase 2/immunology/*metabolism
;
Drug Therapy, Combination
;
Gastric Mucosa/*enzymology
;
Helicobacter Infections/drug therapy
;
*Helicobacter pylori
;
Humans
;
Nitric Oxide Synthase Type II/immunology/*metabolism
;
Time Factors
5.Cloning of the gene encoding urease subunit A in Helicobacter pylori.
Li SHI ; Yijun ZHANG ; Jie CHEN ; Xiaohua HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(1):22-24
The gene encoding urease subunit A (ureA) of Helicobacter pylori (H. pylori) was cloned from H. pylori isolate by polymerase chain reaction (PCR). Sterile distilled water instead of DNA served as negative control. The nucleotide sequence of the amplified product was determined. Homologous analysis of the ureA against that reported by Clayton CL and the GenBank and SwissProt databases were performed with the BLAST program at the Genome Net through the Internet. 0.8 kb PCR product was amplified from all H. pylori clinical isolators. The nucleotide sequence of the ureA was determined. The nucleotide sequence of the ureA began with ATG as the initiation codon and terminated in TAA as stop codon. The coding regions had a 44% G + C content. The DNA sequence was 98% homologous to that reported by Clayton CL (688 out of 702 residues were identical). The derived amino-acid sequences of the ureA were 99% homologous to that reported by Clayton CL (232 out of 234 residues were identical). The nucleotide sequence and the predicted protein showed significant homology to ureA of H. pylori in the NCBI Entrez database.
Base Sequence
;
Cloning, Molecular
;
DNA, Bacterial
;
chemistry
;
genetics
;
Genes, Bacterial
;
Genetic Code
;
Helicobacter Infections
;
microbiology
;
Helicobacter pylori
;
enzymology
;
genetics
;
isolation & purification
;
Humans
;
Molecular Sequence Data
;
Polymerase Chain Reaction
;
Sequence Analysis, DNA
;
Transcription, Genetic
;
Urease
;
genetics
;
metabolism
6.Immunization with catalase and UreB two-valence vaccine for preventing Helicobacter pylori infection in mice.
Huan-jian LIN ; Qin YANG ; Jing LI ; Ying LIU ; Qi-yi WANG
Journal of Southern Medical University 2008;28(3):436-437
OBJECTIVETo investigate the effects of the two-valence vaccine consisting of Helicobacter pylori (H. pylori) catalase and urease subunit UreB in preventing H. pyloriinfection in mice.
METHODSC57BL/6 mice were divided into 7 groups and immunized with intragastric administration of catalase and UreB (both 100 microg) plus cholera toxin (CT, 2 microg), catalase (100 microg) plus CT (2 microg), UreB (100 microg) plus CT (2 microg), catalase (100 microg), UreB (100 microg), CT (2 microg), or PBS, respectively, once a week for 4 consecutive weeks. Two weeks after the last immunization, all the mice were challenged by live H. pylori, and sacrificed 4 weeks after the challenge to obtain the gastric mucosa samples for detecting H. pylori using semi-quantitative bacterial culture assay.
RESULTSThe total protection rate in mice immunized with the two-valence vaccine, single-valence vaccine of catalase, and single-valence vaccine of UreB was 83.3% (20/24), 41.7% (10/24) and 54.2% (13/24), respectively, and the rate in the other 4 groups were all 0. The H. pyloricolony density in mice with vaccination was significantly lower than that of other 4 groups (P<0.05). The total protection rate and H. pylori colony density differed significantly between the two-valence vaccination group and the single-valence vaccination groups (P<0.05).
CONCLUSIONThe two-valence vaccine consisting of catalase, UreB and adjuvant has better immunoprotective effects than the single-valence vaccines.
Animals ; Bacterial Proteins ; immunology ; Bacterial Vaccines ; immunology ; Catalase ; immunology ; Helicobacter Infections ; immunology ; prevention & control ; Helicobacter pylori ; enzymology ; immunology ; Immunization ; methods ; Male ; Mice ; Mice, Inbred C57BL ; Random Allocation ; Urease ; immunology
7.Prevalence and Clinical Characterization of Gastric Helicobacter Species Infection of Dogs and Cats in Korea.
Cheol Yong HWANG ; Hong Ryul HAN ; Hwa Young YOUN
Journal of Veterinary Science 2002;3(2):123-133
This study was carried out to evaluate the prevalence and clinical characterizations of gastric Helicobacter spp. infection of dogs and cats in Korea. The prevalence of Helicobacter spp. infection of dogs and cats determined by urease test was 78.4% and 64%, respectively, although Helicobacter genus-specific PCR assay showed that it was 82.3% and 84%. Urease mapping results based on urease test showed that total positive rate of tested tissues from clinically abnormal dogs was significantly higher than that from clinically normal dogs (p=0.0018; Odds ratio = 6.118; 95% Confidence Interval = 1.96~19.103). These findings were consistent with the results of Helicobacter genus-specific PCR assay which showed that positive rate of the fundus (100%) and the antrum (100%) of clinically abnormal dogs was significantly higher than that of same gastric regions of clinically normal dogs (77.5 and 67.5% respectively). In comparison of gastric regions between clinically normal dogs and abnormal dogs, positive rate of urease test for the fundus (100%) and body (90.9%) in clinically abnormal dogs was significantly higher than that of abnormal dogs (72.5% and 57.5% respectively; p<0.05). The results of urease mapping in dogs and cats also indicated that Helicobacter colonization in the fundus was more dense compared with the density in the body and antrum. In Helicobacter species-specific PCR assay for dogs, 32 of 42 fundic tissues (76.2%) were positive for H. heilmannii and two (4.8%) were positive for H. felis. In cats, 18 of 21 fundic tissues (85.7%) were positive for H. heilmannii and 2 (9.5%) were positive for H. felis. Gastritis scores of fundic tissues from clinically abnormal infected dogs were similar to that from noninfected dogs and evidence of upregulation of IL-1beta, IL-8, and TNF-alpha mRNA was not detected in gastric fundic tissues from clinically abnormal infected dogs. This study suggested that Helicobacter spp. infection in domestic dogs including private owned pet dogs and cats is highly prevalent usually with no clinical sign but high density of colonization can be related to gastrointestinal signs
Animals
;
Cat Diseases/enzymology/*epidemiology/microbiology
;
Cats
;
Cytokines/genetics
;
DNA, Bacterial/analysis/genetics
;
Dog Diseases/enzymology/*epidemiology/microbiology/pathology
;
Dogs
;
Gene Expression Regulation
;
Helicobacter/classification/genetics/isolation&purification
;
Helicobacter Infections/*epidemiology/microbiology/pathology/*veterinary
;
Korea/epidemiology
;
Polymerase Chain Reaction
;
Prevalence
;
RNA, Messenger/genetics/metabolism
;
Species Specificity
;
Stomach/microbiology
;
Stomach Diseases/enzymology/*epidemiology/microbiology/*veterinary
;
Urease/metabolism
8.Cloning of the gene encoding urease subunit A in Helicobacter pylori.
Li, SHI ; Yijun, ZHANG ; Jie, CHEN ; Xiaohua, HOU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2004;24(1):22-4
The gene encoding urease subunit A (ureA) of Helicobacter pylori (H. pylori) was cloned from H. pylori isolate by polymerase chain reaction (PCR). Sterile distilled water instead of DNA served as negative control. The nucleotide sequence of the amplified product was determined. Homologous analysis of the ureA against that reported by Clayton CL and the GenBank and SwissProt databases were performed with the BLAST program at the Genome Net through the Internet. 0.8 kb PCR product was amplified from all H. pylori clinical isolators. The nucleotide sequence of the ureA was determined. The nucleotide sequence of the ureA began with ATG as the initiation codon and terminated in TAA as stop codon. The coding regions had a 44% G + C content. The DNA sequence was 98% homologous to that reported by Clayton CL (688 out of 702 residues were identical). The derived amino-acid sequences of the ureA were 99% homologous to that reported by Clayton CL (232 out of 234 residues were identical). The nucleotide sequence and the predicted protein showed significant homology to ureA of H. pylori in the NCBI Entrez database.
Base Sequence
;
Cloning, Molecular
;
DNA, Bacterial/chemistry
;
DNA, Bacterial/genetics
;
*Genes, Bacterial
;
Genetic Code
;
Helicobacter Infections/microbiology
;
Helicobacter pylori/enzymology
;
Helicobacter pylori/*genetics
;
Helicobacter pylori/isolation & purification
;
Molecular Sequence Data
;
Polymerase Chain Reaction
;
Sequence Analysis, DNA
;
Transcription, Genetic
;
Urease/*genetics
;
Urease/metabolism
9.The Effects of Broccoli Sprout Extract Containing Sulforaphane on Lipid Peroxidation and Helicobacter pylori Infection in the Gastric Mucosa.
Young Woon CHANG ; Jae Young JANG ; Yong Ho KIM ; Jung Wook KIM ; Jae Jun SHIM
Gut and Liver 2015;9(4):486-493
BACKGROUND/AIMS: The aims of this study were to investigate whether a broccoli sprout extract containing sulforaphane (BSES) inhibited the Helicobacter pylori infection density and exerted an antioxidative effect on gastric mucosal damage. METHODS: The enrolled subjects were randomized in a double-blinded manner into three groups. Finally, 33 H. pylori (+) BSES treatment subjects (group A), 28 H. pylori (+) placebo subjects (group B), and 28 H. pylori (-) BSES treatment subjects (group C) were studied. H. pylori infection density was indirectly quantified by a 13C-urea breath test (UBT), and the ammonia concentration in gastric juice aspirates was measured through gastroscopic examination. Malondialdehyde (MDA), an oxidative damage biomarker, and reduced glutathione (GSH), an antioxidant biomarker, were measured in the gastric mucosa by an enzyme-linked immunosorbent assay. RESULTS: BSES treatment did not significantly affect the UBT values or ammonia concentration in group A (p=0.634 and p=0.505, respectively). BSES treatment did significantly reduce mucosal MDA concentrations in group A (p<0.05) and group C (p<0.001), whereas the gastric mucosal GSH concentrations did not differ before and after treatment in any of the groups. CONCLUSIONS: BSES did not inhibit the H. pylori infection density. However, BSES prevented lipid peroxidation in the gastric mucosa and may play a cytoprotective role in H. pylori-induced gastritis.
Adult
;
Ammonia/metabolism
;
Antioxidants/*pharmacology
;
Biomarkers/analysis
;
Brassica/*chemistry
;
Breath Tests
;
Double-Blind Method
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Gastric Juice/enzymology
;
Gastric Mucosa/*drug effects/metabolism
;
Glutathione/analysis
;
Helicobacter Infections/*drug therapy
;
*Helicobacter pylori
;
Humans
;
Isothiocyanates/*pharmacology
;
Lipid Peroxidation/*drug effects
;
Male
;
Malondialdehyde/analysis
;
Middle Aged
;
Plant Extracts/chemistry/*pharmacology
;
Urea
10.New monoclonal antibody-based test for Helicobacter pylori urease in gastric tissue.
Do Hyun KIM ; Ho Dong KIM ; Hyeuk PARK ; Seung CHOI ; Jae Won BEOM ; Woo Jong KIM ; Chang Kook PARK ; Young Jik LEE ; Ju Young PARK ; Hyung Rag KIM ; Chul PARK ; Young Eun JOO ; Young Do JUNG
The Korean Journal of Internal Medicine 2016;31(1):40-45
BACKGROUND/AIMS: To evaluate a new monoclonal antibody for Helicobacter pylori urease in gastric tissue. METHODS: A total of 107 volunteers were enrolled. All subjects underwent a 13C-urea breath test and esophagogastroduodenoscopy. Gastric aspirates were analyzed for pH and ammonia. Six biopsy specimens in the gastric antrum and body were obtained for a rapid urease test and histology. The new monoclonal antibody-based H. pylori urease test (HPU) was performed to rapidly and qualitatively detect urease in two biopsy specimens. RESULTS: H. pylori infection was diagnosed in 73 subjects. The sensitivity and specificity of the HPU was 89% and 74%, respectively. The subjects were divided into two groups: one with true-positive and true-negative HPU results (n = 90) and the other with false-positive and false-negative HPU results (n = 17). Across all subjects, ammonia levels were 900.5 +/- 646.7 and 604.3 +/- 594.3 mumol/L (p > 0.05), and pH was 3.37 +/- 1.64 and 2.82 +/- 1.51 (p > 0.05). Sensitivity was higher in the presence of atrophic gastritis or intestinal metaplasia. CONCLUSIONS: HPU detected H. pylori in approximately 10 min. Gastric aspirate ammonia and pH levels did not affect the test results. Sensitivity was good in the presence of atrophic gastritis or intestinal metaplasia.
Adult
;
Antibodies, Monoclonal/*immunology
;
Bacterial Proteins/*analysis/immunology
;
Biomarkers/analysis
;
Biopsy
;
False Negative Reactions
;
False Positive Reactions
;
Female
;
Gastritis, Atrophic/*diagnosis/microbiology
;
Helicobacter Infections/*diagnosis/microbiology
;
Helicobacter pylori/*enzymology/immunology
;
Humans
;
*Immunologic Tests
;
Male
;
Metaplasia
;
Middle Aged
;
Predictive Value of Tests
;
Pyloric Antrum/*microbiology/pathology
;
Reproducibility of Results
;
Time Factors
;
Urease/*analysis/immunology
;
Workflow